Chemed Corp (NYSE:CHE)
$ 565.98 3.93 (0.7%) Market Cap: 8.48 Bil Enterprise Value: 8.31 Bil PE Ratio: 28.60 PB Ratio: 6.86 GF Score: 94/100

Chemed Corp at Credit Suisse Healthcare Conference - Scottsdale Transcript

Nov 13, 2019 / 05:20PM GMT
Release Date Price: $408.89 (+0.17%)
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

All right. I think we'll get going again. My name is A.J. Rice. I'm the health care service analyst at Credit Suisse. And next up in this room is Chemed.

We're pleased to have Kevin McNamara, President and CEO; David Williams, EVP and Chief Financial Officer; and Nick Westfall, President and CEO of the company, of one of the key operating units.

I always -- have been starting these off with asking the question of when you think about where you were at the beginning of the year versus 11 months in now, what would have been some of the surprises for you, both positive or if there have been any challenges. Maybe I'll just -- that's an open-ended question, but throw that out and have you guys respond.

Questions & Answers

Kevin J. McNamara
Chemed Corporation - CEO, President & Director

Okay. Let me start and I'll turn it over to Nick. It's a health care conference, so answer questions on the health care side. But let me start

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot